Boston Bio Systems Board of Directors
Get the latest insights into the leadership at Boston Bio Systems. Learn about the experienced professionals guiding the company's strategy and governance.
| Name | Position |
|---|---|
| Mr. Pratik Satish Patil | Managing Director |
| Ms. Sadhana Satish Pati | Whole Time Director |
| Mr. Aashish Shrirang Dharmadhikari | Independent Director |
| Mr. Swati Suresh Dhadve | Independent Director |
| Ms. Ghanshyam Dhananjay Gavali | Independent Director |
| Ms. Manpreet Doad Powani | Chief Financial Officer |
Boston Bio Systems Share price
BOSTONBIO
8.48
0.22 (-2.53%)Last updated on 4 Sep, 2025 | 14:48 IST
BUYSELL
Today's High
9.10
Today's Low
8.27
52 Week Low
6.53
52 Week High
22.00
The current prices are delayed, login to your account for live prices
LoginBoston Bio Systems FAQs
The board at Boston Bio Systems consists of experienced professionals, including Mr. Pratik Satish Patil , Ms. Sadhana Satish Pati , and others, overseeing the company’s strategic and corporate governance.
Directors at Boston Bio Systems are typically nominated by the Nomination and Remuneration Committee and approved by shareholders, adhering to regulatory and governance standards. While this is the standard procedure, the exact process may differ depending on the company’s internal policies and governance framework.
As of the latest update, Mr. Pratik Satish Patil is the current chairman at Boston Bio Systems.
Executive directors at Boston Bio Systems are involved in day-to-day operations, while non-executive directors, including independents, provide oversight and strategic input. While this distinction is generally followed, the specific responsibilities of executive and non-executive directors may vary based on the company’s organisational structure and governance practices.
Yes, Boston Bio Systems adheres to all applicable SEBI and Companies Act provisions related to board structure, diversity, and independence.
At Boston Bio Systems, board members usually serve fixed terms as outlined in the company’s charter or governance policy, commonly ranging between three to five years, with the possibility of renewal based on performance, shareholder approval, and regulatory norms.